loading...| Preferred Name |
Raltegravir |
|
| Synonyms |
Raltegravir RALTEGRAVIR N-(2-(4-(4-Fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide MK-0518 |
|
| Definitions |
A small molecule with activity against human immunodeficiency virus (HIV). Raltegravir is an integrase inhibitor that blocks the integration of the viral genome into the host DNA, a critical step in the pathogenesis of HIV. |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C72837 |
|
| CAS_Registry |
518048-05-0 |
|
| Chemical_Formula |
C20H21FN6O5 |
|
| code |
C72837 |
|
| Concept_In_Subset | ||
| Contributing_Source |
FDA |
|
| DEFINITION |
A small molecule with activity against human immunodeficiency virus (HIV). Raltegravir is an integrase inhibitor that blocks the integration of the viral genome into the host DNA, a critical step in the pathogenesis of HIV. |
|
| FDA_UNII_Code |
22VKV8053U |
|
| FULL_SYN |
Raltegravir RALTEGRAVIR N-(2-(4-(4-Fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide MK-0518 |
|
| Has_Salt_Form | ||
| label |
Raltegravir |
|
| Legacy Concept Name |
Raltegravir |
|
| Preferred_Name |
Raltegravir |
|
| prefixIRI |
Thesaurus:C72837 |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C1871526 |
|
| subClassOf |